Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/INCANNEX-HEALTHCARE-INC-133985168/noticia/Incannex-inicia-la-dosificaci-n-en-el-ensayo-cl-nico-de-fase-2-que-eval-a-IHL-675A-en-pacientes-c-45807381/?utm_source=whatsapp&utm_medium=social&utm_campaign=share